Skip to content

Sağlama record · BIST: GENIL

Gen İlaç

Gen İlaç (GENIL) shares are on Borsa Istanbul's participation index list (BIST Participation All Shares) for the period from October 1, 2026 to April 30, 2027. Source: Borsa Istanbul's list of participation index constituents, Oct 1, 2026. The shares are also in the BIST Participation Dividend index.

Dated October 17, 2026No. SGL-2026-6A-GENIL

Based on the financial statements for the first half of 2026, all three ratios are within the TKBB thresholds.

This is a measurement, not a religious ruling.

MEASUREMENT TABLE

Interest-bearing loans

within the threshold
24.0%

Upper bound

Calculation and source

Calculation: numerator ÷ denominatorTRY 5,650,320,718÷TRY 23,576,483,003 (total assets)× 100

RatioInterest-bearing loans / total assets

Upper bound. Debt items that may count as interest-bearing (line 6I of the KAFİF form) were taken in full from the public statements. Debts proven not to count (line 6J of the KAFİF form) were deducted as far as the notes prove them; items that could not be separated stayed in the numerator, as a precaution. Of the lease liabilities shown on the balance sheet, TRY 47,679,453 are debts that do not count under TKBB Guideline 6.2, so they were deducted from the debt numerator (source: balance sheet, page 4). The ratio is therefore an upper bound for the items shown in the financial statements. Note 8: “Ortaklara Borçlar” TRY 17,055,035: undetermined, kept in the upper bound; “Ödenecek Vergi ve Fonlar” TRY 3,738,352: not counted (proven); “Diğer” TRY 356,913,746: undetermined, kept in the upper bound. Notes that could not be used: Note 5 (Short-term borrowings): the note's amounts could not be matched to this item automatically. Note 5 (Current portion of long-term borrowings): the note's amounts could not be matched to this item automatically. Note 5 (Long-term borrowings): the current-period amounts of the note's lines could not be read automatically. The ratio is in the range 0.00% to 23.97%; both bounds give the same result.

Breakdown from the notes
Item, as written in the company's reportAmount (TRY)ClassBasis
Ortaklara Borçlar · Other payables, note 817,055,035undetermined, kept in the upper boundTKBB Guideline 6.1
Ödenecek Vergi ve Fonlar · Other payables, note 83,738,352not counted (proven)TKBB Guideline 6.2
Diğer · Other payables, note 8356,913,746undetermined, kept in the upper boundTKBB Guideline 4.1

KAFİF declaration 19.2% (first half 2026) · Sağlama range 0.0% to 24.0% (first half 2026) · the declaration is inside the range · View the form on KAP

Source: company financial report, first half 2026 statements · Jun 30, 2026

Interest-bearing assets

within the threshold
8.9%

Upper bound

Calculation and source

Calculation: numerator ÷ denominatorTRY 2,098,959,548÷TRY 23,576,483,003 (total assets)× 100

RatioInterest-bearing cash and securities / total assets

Upper bound. Asset items that may count as interest-bearing (line 5F of the KAFİF form) were taken in full from the public statements. Assets proven not to count (line 5G of the KAFİF form) were deducted as far as the notes prove them; items that could not be separated stayed in the numerator, as a precaution. The ratio is therefore an upper bound for the items shown in the financial statements. Note 12: “One Life Ventures Girişim Sermayesi” TRY 149,455,858: undetermined, kept in the upper bound; “Hisse Senetleri” TRY 0: undetermined, kept in the upper bound; “Gen Pharma Caucasus Manifactur (*******)” TRY 888,620,809: undetermined, kept in the upper bound; “RS Araştırma Eğitim A.Ş. (*)” TRY 537,901,314: undetermined, kept in the upper bound; “Neo Auvra San. ve Tic. A.Ş. (***)” TRY 293,419,029: undetermined, kept in the upper bound; “Stimusil Inc. (**)” TRY 125,305,020: undetermined, kept in the upper bound; “H2O Bilişim Yaz.Elekt.Sağ.Hiz.A.Ş.(*****)” TRY 70,687,730: undetermined, kept in the upper bound; “Galventa A. G (**)” TRY 21,391,735: undetermined, kept in the upper bound; and 2 more lines. Note 4: “Kasa” TRY 236,759: not counted (proven); “Banka / - Vadesiz mevduat” TRY 73,755,954: not counted (proven); “Banka / -Vadeli mevduat / TL O/N Temmuz 2026” TRY 5,441,931: counted in the ratio (proven); “Banka / Diğer menkul kıymetler” TRY 0: undetermined, kept in the upper bound. The ratio is in the range 0.02% to 8.90%; both bounds give the same result.

Breakdown from the notes
Item, as written in the company's reportAmount (TRY)ClassBasis
One Life Ventures Girişim Sermayesi · Financial investments, note 12149,455,858undetermined, kept in the upper bound
Hisse Senetleri · Financial investments, note 120undetermined, kept in the upper boundTKBB Guideline 5.2
Gen Pharma Caucasus Manifactur (*******) · Financial investments, note 12888,620,809undetermined, kept in the upper bound
RS Araştırma Eğitim A.Ş. (*) · Financial investments, note 12The company's note says: “Şirket’in finansal yatırımlarından RS Araştırma Eğitim A.Ş. %13,65 pay karşılığında 537.901.314 TL tutarındaki hisseden oluşmaktadır. İstanbul Portföy Yönetimi A.Ş. tarafından 15 Aralık 2025 tarihinde hazırlanmış değerleme raporuna göre değer düşüklüğü söz konusu olmadığı için Şirket maliyet bedeli ile finansal tablolarda muhasebeleştirilmiştir.”537,901,314undetermined, kept in the upper bound
Neo Auvra San. ve Tic. A.Ş. (***) · Financial investments, note 12The company's note says: “Şirket’in finansal yatırımlarından Neo Auvra %32,39 pay karşılığında 293.419.029 TL tutarındaki hisseden oluşmaktadır. İstanbul Portföy Yönetimi A.Ş. tarafından 24 Aralık 2024 tarihinde hazırlanmış değerleme raporuna göre değer düşüklüğü söz konusu olmadığı için Şirket maliyet bedeli ile finansal tablolarda muhasebeleştirilmiştir. Şirket’in %32,39 oranında hissedar olduğu Neo Auvra San. ve Tic. A.Ş ‘ye vermiş olduğu 700.000 USD tutarındaki paya dönüştürülebilir borç paya dönüşmüş ve ayrıca Gen İlaç tarafından aynı şirketten 500.000 USD karşılığında hisse alınmıştır. Paya dönüşüm ve ek yatırım karşılığında Gen İlaç A.Ş. ’nin Neo Auvra San. ve Tic. A.Ş’ deki hissedarlık oranı %35,15’e yükselmiştir.”293,419,029undetermined, kept in the upper bound
Stimusil Inc. (**) · Financial investments, note 12The company's note says: “Söz konusu finansal yatırımlar 2021 yılı aralık ayında kurulan yeni şirketler olup değer düşüklüğü söz konusu olmadığı için maliyet bedeli ile finansal tablolarda sunulmaktadır.”125,305,020undetermined, kept in the upper bound
H2O Bilişim Yaz.Elekt.Sağ.Hiz.A.Ş.(*****) · Financial investments, note 1270,687,730undetermined, kept in the upper bound
Galventa A. G (**) · Financial investments, note 12The company's note says: “Söz konusu finansal yatırımlar 2021 yılı aralık ayında kurulan yeni şirketler olup değer düşüklüğü söz konusu olmadığı için maliyet bedeli ile finansal tablolarda sunulmaktadır.”21,391,735undetermined, kept in the upper bound
Invios GMBH (****) · Financial investments, note 12The company's note says: “Şirket, Invios Holding AG’nin %0,979’a hissesine sahiptir. Yapılan kontroller sonucunda değer düşüklüğü söz konusu olmadığı için Şirket maliyet bedeli ile finansal tablolarda muhasebeleştirmiştir.”6,214,215undetermined, kept in the upper bound
Jaguar Health Inc. (******) · Financial investments, note 12521,907undetermined, kept in the upper bound
Kasa · Cash and cash equivalents, note 4236,759not counted (proven)TKBB Guideline 5.2
Banka / - Vadesiz mevduat · Cash and cash equivalents, note 473,755,954not counted (proven)TKBB Guideline 5.2
Banka / -Vadeli mevduat / TL O/N Temmuz 2026 · Cash and cash equivalents, note 45,441,931counted in the ratio (proven)TKBB Guideline 5.1
Banka / Diğer menkul kıymetler · Cash and cash equivalents, note 40undetermined, kept in the upper boundTKBB Guideline 5.1

KAFİF declaration 0.0% (first half 2026) · Sağlama range 0.0% to 8.9% (first half 2026) · the declaration is inside the range · View the form on KAP

Source: company financial report, first half 2026 statements · Jun 30, 2026

Excluded income

within the threshold
2.0%

Measured on the items we can calculate

Calculation and source

Calculation: numerator ÷ denominatorTRY 291,618,251÷TRY 14,434,306,559 (total income)× 100

RatioExcluded income / total income

On the KAP form this item is titled “Katılım Finans İlkelerine Uygun Olmayan Gelir”, which means income not in line with participation finance principles.

Measured on the items we can calculate. Income items that may count as excluded (line 4C of the KAFİF form) were taken in full from the public statements. Income that the notes prove does not count (line 4D of the KAFİF form) was deducted. Items that could not be separated stayed in the numerator, as a precaution. For these income lines (line 4C), the ratio is an upper bound. Excluded income from business activities (line 4B of the KAFİF form) does not appear in the financial statements; it is only in the company's KAFİF declaration on KAP. This measurement sets it to 0. If there is a declaration, the record shows it separately, with a link. Note 21: “Kur Gelirleri” TRY 112,705,859: undetermined, kept in the upper bound; “Faiz Gelirleri” TRY 78,053,843: counted in the ratio (proven); “Sigorta Tazminat Gelirleri” TRY 28,403,926: not counted (proven); “Konusu Kalmayan Dava Karşılıkları” TRY 7,481,881: not counted (proven); “Tazminat Gelirleri” TRY 0: not counted (proven); “Fiyat Fark Gelirleri” TRY 0: undetermined, kept in the upper bound; “Diğer” TRY 39,643,435: undetermined, kept in the upper bound. Note 23: “Faiz Gelirleri” TRY 50,876,434: counted in the ratio (proven); “Kur Farkı Gelirleri” TRY 19,849,910: not counted (proven). Note 22: “Sabit Kıymet Satış Karı” TRY 25,377,551: not counted (proven); “Menkul Kıymet Satış Karları” TRY 10,338,680: undetermined, kept in the upper bound; “Kira Gelirleri” TRY 6,413,008: not counted (proven); “Temettü Gelirleri” TRY 0: undetermined, kept in the upper bound. The ratio is in the range 0.89% to 2.02%; both bounds give the same result.

Breakdown from the notes
Item, as written in the company's reportAmount (TRY)ClassBasis
Kur Gelirleri · Other income from operating activities, note 21112,705,859undetermined, kept in the upper bound
Faiz Gelirleri · Other income from operating activities, note 2178,053,843counted in the ratio (proven)TKBB Guideline 4.1
Sigorta Tazminat Gelirleri · Other income from operating activities, note 2128,403,926not counted (proven)TKBB Guideline 4.2
Konusu Kalmayan Dava Karşılıkları · Other income from operating activities, note 217,481,881not counted (proven)TKBB Guideline 4.2
Tazminat Gelirleri · Other income from operating activities, note 210not counted (proven)TKBB Guideline 4.2
Fiyat Fark Gelirleri · Other income from operating activities, note 210undetermined, kept in the upper bound
Diğer · Other income from operating activities, note 2139,643,435undetermined, kept in the upper boundTKBB Guideline 4.1
Faiz Gelirleri · Finance income, note 2350,876,434counted in the ratio (proven)TKBB Guideline 4.1
Kur Farkı Gelirleri · Finance income, note 2319,849,910not counted (proven)TKBB Guideline 4.2
Sabit Kıymet Satış Karı · Income from investing activities, note 2225,377,551not counted (proven)TKBB Guideline 4.2
Menkul Kıymet Satış Karları · Income from investing activities, note 2210,338,680undetermined, kept in the upper boundTKBB Guideline 4.1
Kira Gelirleri · Income from investing activities, note 226,413,008not counted (proven)TKBB Guideline 4.2
Temettü Gelirleri · Income from investing activities, note 220undetermined, kept in the upper boundTKBB Guideline 4.2

KAFİF declaration 0.9% (first half 2026) · Sağlama range 0.9% to 2.0% (first half 2026) · the declaration is inside the range · View the form on KAP

Source: company financial report, first half 2026 statements · Jun 30, 2026

The three ratios are calculated from the financial statements, and each bar is scaled to its own threshold. The measurement uses the company's latest published statements, and every record states the period. The official review uses audited six- and twelve-month statements (Standard 3.4), so the periods can differ. Method

This record is produced by Sağlama's calculation from the financial statements the company publishes. The method and the corrections log are public. Responsible for this record: Savaş Tutumlu, founder.

Official list record

Official list
On the BIST Participation All Shares list · Index period from October 2026 to April 2027Source: Borsa Istanbul's list of constituents, Oct 1, 2026
In these sub-indices
BIST Participation Dividend
Latest official change

Removed from the BIST Participation 30, BIST Participation 50 and BIST Participation 100 indices as of October 1, 2026, for the period from October 2026 to April 2027. Source: Borsa Istanbul announcement, Sep 29, 2026 · KAP disclosure 1669816

All changes for the period from October 2026 to April 2027

Next period
Starts on May 1, 2027. Borsa Istanbul is expected to announce the new list by April 29, 2027 at the latest (Ground Rules 2.17). Sağlama's expectation for each member is on the Review forecast page. This is a forecast, not the official list.

Status history

6 entries

Each period's record and every correction are kept with their dates. Method

  1. Earlier measurementTKBB rules, August 2025, version 1 · Q1 2026: all three ratios within the threshold. Income 2.33% · assets 12.99% · loans 21.39%.
  2. Earlier measurementTKBB rules, August 2025, version 1 · Q1 2026: all three ratios within the threshold. Income 2.82% · assets 12.99% · loans 21.39%.
  3. Earlier measurementTKBB rules, August 2025, version 1 · Q1 2026: all three ratios within the threshold. Income 2.60% · assets 12.99% · loans 21.37%.
  4. Earlier measurementTKBB rules, August 2025, version 2 · Q1 2026: all three ratios within the threshold. Income 2.60% · assets 12.99% · loans 21.37%.
  5. Earlier measurementTKBB rules, August 2025, version 2 · first half 2026: all three ratios within the threshold. Income 2.02% · assets 8.90% · loans 24.17%.
  6. MeasurementTKBB rules, August 2025, version 3 · first half 2026: all three ratios within the threshold. Income 0.89% to 2.02% · assets 0.02% to 8.90% · loans 0.00% to 23.97%.THIS RECORD

Documents and sources

Source links lead to documents published by the company and by Borsa Istanbul. We do not copy KAP documents. Method

  • GENIL financial report, Jun 30, 2026 (company investor relations site)Jun 30, 2026 · Fingerprint 931aa5fdac5d…View the document
  • Sağlama's calculation and methodTKBB rules, August 2025, version 3Read the method

If a figure looks wrong, write to bilgi@saglama.com. We correct it and record the correction with its date in the corrections log.

What this measurement covers

Based on data as of this date, the three ratios we measure are within the TKBB thresholds.

The company's KAFİF declaration

The company's declaration on the KAP form (first half 2026): excluded income 0.9%, interest-bearing assets 0.0%, interest-bearing loans 19.2%. The three declared ratios are within the thresholds. View the form on KAP

The company's answers to the four yes/no questions on the form:

Do the articles of association of the company, its corporate shareholders or its affiliates include an activity that does not follow participation finance principles?
No
Do the company's articles of association grant a privilege that does not follow participation finance principles?
No
Has the company made a statement or decision supporting the actions defined in Standard 1.5 and TKBB Guideline 1.D?
No
Does the company have activities or income directly contrary to participation finance principles?
No

Purification calculation

Dividend-based method · CALCULATOR (DIVIDEND-BASED METHOD)

Purification calculator

A company within the threshold can still have a small amount of excluded income (interest income and other income the standard excludes). Under the TKBB standard, the part of this income that falls to your shares is given to charitable causes. This duty applies whether the company made a profit or a loss, and whether or not it paid a dividend. The amount set aside does not replace zakat or sadaqa.

CALCULATION SLIPGENIL · first half 2026
Number of shares
500
Gross dividend per share
TRY 2.40
Gross dividend (500 × 2.40)
TRY 1,200.00
Excluded income ratio
2.0%
Purification amount
TRY 24.24

Purification amount = gross dividend × excluded income ratio

The number of shares and the dividend are sample inputs. The ratio comes from the company's measurement. To calculate with your own figures, use the purification page.

Purification amount = gross dividend × excluded income ratio (dividend-based method). Under TKBB Standard 3.6.1, purification is needed even if the company makes a loss or pays no dividend. The method page quotes TKBB Standard 3.6, including the inflation deduction under 3.6.2. This is a cautious calculation. The amount may be higher than the true figure, because it uses all of the interest income, not only the part above inflation. The ratio is the upper bound of the measurement (the lower bound is 0.89%); the purification amount is calculated on the upper bound, as a precaution.

  • Excluded income is the part of a company's earnings that is not in line with participation finance principles. On the KAP form it is called “income not in line with participation finance principles.”
  • Purification is done even if the company makes a loss.
  • Purification is needed even if no dividend is paid. The calculation here uses the dividend-based method. TKBB Standard 3.6 also counts how long you held the shares (the share-days method), which this calculator does not do yet.
  • The purification amount does not replace zakat or sadaqa. Under the TKBB standard, it is given away, not kept.
  • You give the amount yourself, to a charitable cause of your choice. Sağlama does not direct donations.

This calculation uses the dividend-based method. TKBB Standard 3.6 also counts how long you held the shares (the share-days method). The standard is quoted on the method page.

Get an alert if it changes

Your address is kept so that we can tell you when the status of GENIL changes. Alerts start when the sending service goes live. At most one or two e-mails a month. You can unsubscribe with one click.

Your address is used only for these alerts.

Companies in the same index

The 12 companies just before and after this one in alphabetical order in BIST Participation All Shares.